Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (351-360 of 367) with videos related to

Pageof 37
Sort By:
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.
British Journal of Cancer|April 3, 2023
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
Advances in Experimental Medicine and Biology|May 11, 2021
Interdisciplinary Approaches to COVID-19Negar Moradian, Marjan Moallemian, Farnaz Delavari, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical PrecancersPhilip E Castle, Amanda J Pierz, Rachael Adcock, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
The Lancet. Oncology|October 5, 2014
Prevention and early detection of prostate cancerJack Cuzick, Mangesh A Thorat, Gerald Andriole, et al.
BMJ Open|January 2, 2020
Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer riskEvenda Dench, Daniela Bond-Smith, Ellie Darcey, et al.
Pageof 37

Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.
British Journal of Cancer|April 3, 2023
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
Advances in Experimental Medicine and Biology|May 11, 2021
Interdisciplinary Approaches to COVID-19Negar Moradian, Marjan Moallemian, Farnaz Delavari, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical PrecancersPhilip E Castle, Amanda J Pierz, Rachael Adcock, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
The Lancet. Oncology|October 5, 2014
Prevention and early detection of prostate cancerJack Cuzick, Mangesh A Thorat, Gerald Andriole, et al.
BMJ Open|January 2, 2020
Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer riskEvenda Dench, Daniela Bond-Smith, Ellie Darcey, et al.
Pageof 37